Accordingly, we hypothesized that RA patients with anti-PAD3/4XR would demonstrate a greater prevalence and extent of RA comorbidities in which tissue citrullination and/or pathogenic ACPA may play an etiopathologic role, such as RA-ILD. The gene discussed is PRTN3; the disease is interstitial lung disease.